B.1.617.2 enters and fuses lung cells with increased efficiency

The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.617.2, emerged in India and has spread to over 80 countries. B.…

SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation

Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant

SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies - ScienceDirect

Frontiers Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future

Full article: Virus-induced senescence: A therapeutic target to mitigate severe progression of SARS-COV-2

Messages from the COVID-19 Response Task Force

P681 mutations within the polybasic motif of spike dictate fusogenicity and syncytia formation of SARS CoV-2 variants

Omicron subvariant BA.5 efficiently infects lung cells

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion

Deutsches Primatenzentrum: Delta and Delta Plus evade the antibody response

Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics, Virology Journal

Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage - ScienceDirect